Although OC phenomena have long been recognized in schizophrenia, few systematic studies have examined its significance in terms of clinical course and underlying neurobiologic correlates.

Researchers Discover a Mechanism That Impairs Synaptic Plasticity in the Brains of Schizophrenia Patients Sep. 4, 2024 — A study mapped genes linked to schizophrenia and uncovered a mechanism ...

Among individuals with schizophrenia, the risk for natural-cause mortality was increased in those with reduced cognitive functioning.

Symptoms of schizophrenia, a serious mental disorder that can include hallucinations and delusions, vary greatly from person to person. One common group of schizophrenia symptoms that doesn’t ...

I have schizoaffective disorder, bipolar type — a combination of schizophrenia and bipolar disorder — and I agree that this is a monumental development for my community. Historically ...

Individuals with emergency department visits involving hallucinogen use are at high risk of developing schizophrenia, ...

Even after controlling for a person’s existing substance use and mental health disorders, there remained a 3.5-fold increased ...

Catatonic depression is also called major depressive disorder with catatonic features ... as a symptom of schizophrenia, research shows that catatonia, or catatonic behavior, can occur alone or at the ...

Caplyta (lumateperone) was approved for the treatment of schizophrenia in 2019 and for depressive episodes linked to bipolar I or bipolar II disorder (bipolar depression) in 2021. Caplyta can be ...

Schizophrenia -- the statistics are terrifying. More than 3.7 million people are living with it right now in the United States. If left untreated it can be disabling, leaving people suffering with ...

About one in 300 people worldwide are affected by schizophrenia, but for decades treatment options have been both static and limited. If the FDA approves the twice-daily pill on Thursday ...

Researchers conducted a cohort study to assess the predictive value of plasma MMP9 in antipsychotic treatment response among patients with schizophrenia.